Keywords: bama-geve, sees, sales, up, spain, italian, drugs
Bama-Geve sees 2005 sales up 13% in Spain
Article | 14 February 2005
Italian drugs company Bama-Geve expects sales to rise 13.0% in Spain this year to 14.5 million euros ($18.9 million), boosted by product launches ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
